CRD-A vs DRUG

Comparison between Crawford & Co. - Class A (CRD-A, Company) and Bright Minds Biosciences Inc (DRUG, Company).

CRD-A is from the Financial Services sector, while DRUG is from the Healthcare sector.

5-Year PerformanceDRUG has outperformed CRD-A, delivering a return of +21.5% compared to +7.0%

CRD-A vs DRUG - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	CRD-A(COMPANY)	DRUG(COMPANY)
Market Cap	$582M	$582M
Max Drawdown	84.40%	97.68%
Sharpe Ratio	0.39	1.38
5Y Beta	0.82	-0.80
Industry	Insurance Brokers	Biotechnology
P/E Ratio	16.05	-24.65
Forward P/E	12.58	N/A
PEG Ratio	N/A	-0.07
Dividend Yield	2.71%	N/A
5Y Dividends CAGR	4.56%	N/A
5Y EPS CAGR	N/A	8.42%
Debt to Equity	24.68%	0.03%
Free Cash Flow Yield	19.08%	-2.50%

Market Cap

Winner

CRD-A

$582M

DRUG

$582M

Max Drawdown

Winner

CRD-A

84.40%

DRUG

97.68%

Sharpe Ratio

CRD-A

0.39

Winner

DRUG

1.38

5Y Beta

CRD-A

0.82

Winner

DRUG

-0.80

Industry

CRD-A

Insurance Brokers

DRUG

Biotechnology

P/E Ratio

CRD-A

16.05

Winner

DRUG

-24.65

Forward P/E

CRD-A

12.58

DRUG

N/A

PEG Ratio

CRD-A

N/A

DRUG

-0.07

Dividend Yield

CRD-A

2.71%

DRUG

N/A

5Y Dividends CAGR

CRD-A

4.56%

DRUG

N/A

5Y EPS CAGR

CRD-A

N/A

DRUG

8.42%

Debt to Equity

CRD-A

24.68%

Winner

DRUG

0.03%

Free Cash Flow Yield

Winner

CRD-A

19.08%

DRUG

-2.50%

CRD-A vs DRUG - Historical Returns

Returns include dividend reinvestment.

Period	CRD-A	DRUG
1 month	+8.92%	-19.12%
3 months	+18.06%	-13.16%
6 months	-3.86%	-23.10%
1 year	+10.40%	+115.18%
5 years(CAGR)	+7.04%	+21.53%
10 years(CAGR)	+6.65%	N/A
Max(CAGR)	+2.87%	+16.70%

Winner

CRD-A

+8.92%

DRUG

-19.12%

Winner

CRD-A

+18.06%

DRUG

-13.16%

Winner

CRD-A

-3.86%

DRUG

-23.10%

CRD-A

+10.40%

Winner

DRUG

+115.18%

5Y(CAGR)

CRD-A

+7.04%

Winner

DRUG

+21.53%

10Y(CAGR)

CRD-A

+6.65%

DRUG

N/A

Max(CAGR)

CRD-A

+2.87%

Winner

DRUG

+16.70%

CRD-A vs DRUG - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	CRD-A	DRUG
2026	+1.34%	-27.32%
2025	+1.73%	+89.83%
2024	-7.92%	+1859.10%
2023	+147.47%	-63.33%
2022	-25.48%	-78.04%
2021	+8.09%	-41.30%
2020	-32.56%	N/A
2019	+34.22%	N/A
2018	+7.57%	N/A
2017	-6.49%	N/A
2016	+97.00%	N/A
2015	-38.28%	N/A
2014	+15.94%	N/A
2013	+36.90%	N/A
2012	+49.04%	N/A
2011	+70.23%	N/A
2010	-24.53%	N/A
2009	-56.34%	N/A
2008	+86.70%	N/A
2007	-42.62%	N/A
2006	+4.59%	N/A
2005	-10.39%	N/A
2004	+3.60%	N/A
2003	+76.03%	N/A
2002	-49.92%	N/A
2001	-9.05%	N/A
2000	-3.54%	N/A
1999	+0.09%	N/A

CRD-A vs DRUG Drawdown Comparison

The maximum drawdown for CRD-A was -82.82%, occurring on Sep 27, 2010. Recovery took 1997 trading sessions.

The maximum drawdown for DRUG was -97.68%, occurring on Jul 11, 2024. Recovery took 740 trading sessions.

The current CRD-A drawdown is -13.34%. The current DRUG drawdown is -36.80%.

Rank	CRD-A	DRUG
#1	-82.82% Aug 11, 2008 - Jul 18, 2016	-97.68% Nov 8, 2021 - Oct 18, 2024
#2	-70.16% Mar 18, 2002 - Aug 11, 2008	-58.28% Nov 6, 2024 - Sep 29, 2025
#3	-52.67% Dec 16, 2019 - Jun 16, 2023	-38.35% Jan 7, 2026 - Jun 15, 2026
#4	-40.76% Feb 26, 2024 - Mar 11, 2024	-27.84% Mar 22, 2021 - Aug 24, 2021
#5	-32.87% Nov 21, 2016 - Feb 1, 2019	-26.13% Oct 21, 2025 - Nov 28, 2025
#6	-30.76% Jun 29, 2001 - Mar 18, 2002	-19.30% Dec 16, 2025 - Jan 7, 2026
#7	-20.81% Mar 5, 2019 - Jun 27, 2019	-16.21% Sep 30, 2025 - Oct 9, 2025
#8	-19.53% Jun 30, 2023 - Nov 20, 2023	-14.42% Oct 11, 2021 - Nov 3, 2021
#9	-17.94% Jan 11, 2000 - Jun 20, 2001	-9.05% Oct 24, 2024 - Nov 4, 2024
#10	-12.24% Jul 18, 2016 - Nov 11, 2016	-7.65% Oct 14, 2025 - Oct 21, 2025
#11	-11.15% Dec 29, 2023 - Feb 15, 2024	-5.42% Dec 11, 2025 - Dec 16, 2025
#12	-9.95% Jul 15, 2019 - Sep 12, 2019	-4.62% Sep 24, 2021 - Sep 29, 2021
#13	-8.21% Feb 19, 2019 - Mar 1, 2019	-4.59% Dec 8, 2025 - Dec 10, 2025
#14	-5.83% Nov 2, 1999 - Dec 22, 1999	-4.38% Aug 24, 2021 - Sep 1, 2021
#15	-5.70% Sep 30, 2019 - Nov 13, 2019	-3.81% Sep 1, 2021 - Sep 17, 2021